Sign in

CIK 0001285819

  • Non-accelerated filer
  • Smaller reporting company

OMEROS CORP

Sign in to watch
Ticker
OMER
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
WA
Entity type
Operating
EIN
911663741
Phone
+1 206-676-5000
Business address
201 ELLIOTT AVENUE WEST, SEATTLE, WA, 98119
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Exercise or conversion Director acquired 10,000 shares (option exercise)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market sale CHAIRMAN, CEO & PRESIDENT sold 73,713 shares at an average $14.96 ($1,102,746)
  12. 4 Open-market sale CHAIRMAN, CEO & PRESIDENT sold 73,713 shares at an average $16.02 ($1,180,515)
  13. 4 Open-market sale CHAIRMAN, CEO & PRESIDENT sold 72,613 shares at an average $17.84 ($1,295,218)
  14. 4 Exercise or conversion Director acquired 10,000 shares (option exercise)
  15. 4 Open-market sale VP FINANCE AND CAO sold 18,100 shares at an average $22.93 ($414,968)
  16. 4 Exercise or conversion Director acquired 5,000 shares (option exercise)
  17. 4 Open-market sale VP FINANCE AND CAO sold 1,900 shares at $22.49 ($42,731)
  18. 4 Open-market sale VP FINANCE AND CAO sold 9,500 shares at $19.95 ($189,525)
  19. 4 Open-market sale Director sold 5,000 shares at $16.97 ($84,850)
  20. 4 Derivatives Options or other derivatives

Page 5 of 15 · 295 filings